Global Latex Agglutination Test Kits Market Size study & Forecast, by Test Type (Antibody Detection, Antigen Testing), by Sample Type (Blood, Urine, Cerebrospinal Fluid (Lumbar Puncture), Others), by End-user (Hospital-based Laboratories, Standalone Clini

Global Latex Agglutination Test Kits Market Size study & Forecast, by Test Type (Antibody Detection, Antigen Testing), by Sample Type (Blood, Urine, Cerebrospinal Fluid (Lumbar Puncture), Others), by End-user (Hospital-based Laboratories, Standalone Clinical Laboratories) and Regional Analysis, 2022-2029

Global Latex Agglutination Test Kits Market is valued at approximately USD 447.2 million in 2021 and is anticipated to grow with a healthy growth rate of more than 4.3% over the forecast period 2022-2029. Latex agglutination test kits are commonly used to detect antibodies or antigens in bodily fluids such as CSF, urine, blood, and saliva. The test kits include antigen or antibody coating on an artificial carrier particle, such as a latex bead. The diverse application areas of latex agglutination test kits, surge in the adoption of point of care (POC) techniques/rapid diagnostics for infectious and autoimmune diseases, coupled with rising government approvals are major driving factors for the market growth across the globe.

The surge in prevalence of infectious and autoimmune diseases is acting as a major catalyzing factor for market growth. According to World Health Organization (WHO) article published in October 2022, tuberculosis (TB) is the 13th biggest cause of death and the second leading infectious disease after COVID-19 (above HIV/AIDS). A total of 10.6 million tuberculosis (TB) cases were anticipated in 2021, with 6.0 million males, 3.4 million women, and 1.2 million children. Thereby, the easing disease burden is fostering the demand for latex agglutination test kits, which, in turn, accelerates market growth at a substantial rate. Moreover, the growing investment in R&D activities, as well as the increasing initiatives by the key market players are presenting various lucrative opportunities over the forecasting years. However, the emergence of new and reliable alternate diagnostics is challenging the market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Latex Agglutination Test Kits Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America dominated the market in terms of revenue, owing to the growing number of Clinical Laboratory Improvement Amendments (CLIA)-certified laboratories, along with the robust usage of these test kits. Whereas, the Asia Pacific is also expected to grow with the highest CAGR during the forecast period, owing to factors such as the rising burden of infectious diseases, geographic expansion of key players, and increasing number of hospital-based laboratories and standalone laboratories in the market space.

Major market players included in this report are:

Atlas Medical GmbH (Germany)
Thermo Fisher Scientific Inc. (U.S.)
Bio-Rad Laboratories, Inc. (U.S.)
HiMedia Laboratories (India)
Pro Lab Diagnostics Inc. (Canada)
Arlington Scientific, Inc. (U.S.)
Hardy Diagnostics (U.S.)
Liofilchem S.r.l. (Italy)
Biotec (Novacyt) (U.K.)
Creative Diagnostics (U.S.)

Recent Developments in the Market:
In July 2022, Bio-Rad Laboratories, Inc. unveiled two products: HAI Negative Run Control for hospital-associated illnesses and Synthetic Negative Run Control for tick-borne, meningitis/encephalitis, and sexually-transmitted infections.

Global Latex Agglutination Test Kits Market Report Scope:

Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Test Type, Sample Type, End-user, Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players.

The detailed segments and sub-segment of the market are explained below:

By Test Type:
Antibody Detection
Antigen Testing

By Sample Type:
Blood
Urine
Cerebrospinal Fluid (Lumbar Puncture)
Others

By End-user:
Hospital-based Laboratories
Standalone Clinical Laboratories

By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
RoLA
Rest of the World

Companies Mentioned

Atlas Medical GmbH (Germany)
Thermo Fisher Scientific Inc. (U.S.)
Bio-Rad Laboratories, Inc. (U.S.)
HiMedia Laboratories (India)
Pro Lab Diagnostics Inc. (Canada)
Arlington Scientific, Inc. (U.S.)
Hardy Diagnostics (U.S.)
Liofilchem S.r.l. (Italy)
Biotec (Novacyt) (U.K.)
Creative Diagnostics (U.S.)

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.